Osteoporosis
Nova Science Publishers Inc (Verlag)
978-1-60692-397-9 (ISBN)
Osteoporosis is a disease of bone that leads to an increased risk of fracture. In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of non-collagenous proteins in bone is altered. Osteoporosis is defined by the World Health Organization (WHO) in women as a bone mineral density 2.5 standard deviations below peak bone mass (20-year-old healthy female average) as measured by DXA; the term "established osteoporosis" includes the presence of a fragility fracture.[1] Osteoporosis is most common in women after menopause, when it is called postmenopausal osteoporosis, but may also develop in men, and may occur in anyone in the presence of particular hormonal disorders and other chronic diseases or as a result of medications, specifically glucocorticoids, when the disease is called steroid- or glucocorticoid-induced osteoporosis (SIOP or GIOP). Given its influence on the risk of fragility fracture, osteoporosis may significantly affect life expectancy and quality of life. This book presents the latest research results in the field.
Preface; Subregional Bone Mineral Density Measurement in the Lumbar Spine using DXA: Potential for the Application to Osteoporosis and Vertebral Fractures; Diagnosis of Osteoporosis Using DXA Technique; Nutritional Treatment in Osteoporosis; A Narritive Review of Glucocorticoid-Induced Bone Loss; Secondary Bone Loss After Stroke: Characteristics and Management; New Perspectives in the Management of Osteoporosis: The OPG/RANKL System; Intermittent Dosing of Calcitrol and Calcitonin Improves Bone Quality and Strength In Previously Ovariectomized Rats; The Role of B Cells in Physiological and Pathological Bone Turnover; Anabolic Agents in the Current Management of Osteoporosis; Physical Exercise and Rehabilitation in the Prevention and Treatment of Osteoporosis; The Role of Periosteum: A Neglected Aspect Of Osteoporosis; Bone Quality: Where Should We Be Looking?; Osteoporosis and Fracture Risk: New Perspectives For Early Diagnosis and Treatment Assessment; Treatment of Osteoporotic Compression Fractures with Vertebroplasty; Drug Induced Osteoporosis: Fracture Risk Associated with Drugs Other Than Corticosteroids; Secondary Osteoporosis: The Role of Thyroid Hormones and Thyroid Stimulating Hormone in Bone Loss - A New Approach to an Old Concept; Bone Mineral Density in Young Females-the Impact of Menstrual Dysfunction; Excessive Iron Accumulation: A New Therapeutic Target of Postmenopausal Osteoporosis by Chelation; Index.
Erscheint lt. Verlag | 20.8.2009 |
---|---|
Zusatzinfo | Illustrations |
Verlagsort | New York |
Sprache | englisch |
Maße | 260 x 180 mm |
Gewicht | 1478 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Orthopädie |
ISBN-10 | 1-60692-397-8 / 1606923978 |
ISBN-13 | 978-1-60692-397-9 / 9781606923979 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich